14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $80.00 Thursday, 25th Apr 2024 AXSM stock ended at $71.52. This is 0.492% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 4.23% from a day low at $69.53 to a day high of $72.47.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Aug 20, 2020 $79.31 $82.00 $78.75 $80.13 496 956
Aug 19, 2020 $80.57 $80.94 $78.68 $78.95 237 521
Aug 18, 2020 $81.60 $82.60 $79.42 $80.26 205 768
Aug 17, 2020 $79.00 $82.29 $79.00 $81.57 269 646
Aug 14, 2020 $79.68 $81.05 $78.46 $79.00 237 516
Aug 13, 2020 $78.16 $80.83 $78.00 $79.76 237 426
Aug 12, 2020 $77.79 $80.25 $77.79 $78.60 348 577
Aug 11, 2020 $81.15 $83.32 $77.18 $77.62 525 618
Aug 10, 2020 $79.03 $83.48 $76.35 $81.79 464 916
Aug 07, 2020 $78.26 $80.29 $76.17 $78.07 391 558
Aug 06, 2020 $75.51 $78.13 $74.92 $78.04 270 943
Aug 05, 2020 $77.56 $77.82 $74.83 $75.71 376 136
Aug 04, 2020 $75.93 $76.55 $73.56 $74.79 425 565
Aug 03, 2020 $71.60 $77.27 $70.52 $76.54 377 628
Jul 31, 2020 $74.54 $75.19 $71.27 $71.33 412 981
Jul 30, 2020 $73.00 $75.50 $72.20 $74.60 259 259
Jul 29, 2020 $76.04 $76.87 $73.55 $74.27 391 097
Jul 28, 2020 $77.39 $78.22 $75.60 $75.74 323 148
Jul 27, 2020 $78.34 $79.00 $75.50 $77.18 447 183
Jul 24, 2020 $79.26 $79.68 $76.81 $77.35 346 801
Jul 23, 2020 $81.94 $83.50 $79.37 $79.90 256 516
Jul 22, 2020 $81.65 $82.30 $79.16 $81.82 254 800
Jul 21, 2020 $84.24 $85.25 $81.34 $81.88 390 100
Jul 20, 2020 $81.32 $85.05 $80.66 $83.51 353 100
Jul 17, 2020 $80.00 $84.70 $79.87 $81.65 346 100
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT